- Home
- CALC
CALC
CalciMedica Inc.
as 01-21-2025 4:00pm EST
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | LA JOLLA |
| Market Cap: | 40.3M | IPO Year: | N/A |
| Target Price: | $18.20 | AVG Volume (30 days): | 25.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.44 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.05 - $8.38 | Next Earning Date: | 11-13-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of CalciMedica Inc. (CALC)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| MIDDLETON FRED A | CALC | Director10% Owner | Dec 6 '24 | Buy | $2.65 | 4,800 | $12,720.00 | 36,514 | |
| MIDDLETON FRED A | CALC | Director10% Owner | Nov 1 '24 | Buy | $3.75 | 107,744 | $404,040.00 | 36,514 | |
| Roberts Eric W | CALC | CHIEF BUSINESS OFFICER | Nov 1 '24 | Buy | $3.75 | 53,333 | $199,998.75 | 164,706 | |
| WILSON ROBERT N | CALC | Director | Nov 1 '24 | Buy | $3.75 | 53,333 | $199,998.75 | 417,529 | |
| Leheny A. Rachel | CALC | CHIEF EXECUTIVE OFFICER | Nov 1 '24 | Buy | $3.75 | 20,000 | $75,000.00 | 130,926 | |
| Sanderling Venture Partners VI Co Investment Fund LP | CALC | 10% Owner | Nov 1 '24 | Buy | $3.75 | 87,744 | $329,040.00 | 814,300 |
Latest CalciMedica Inc. News
CALC Breaking Stock News: Dive into CALC Ticker-Specific Updates for Smart Investing
PR Newswire
8 days ago
CalciMedica Announces Appointment of Dr. Alan Glicklich to Board of Directors
PR Newswire
2 months ago
CalciMedica to Participate in the Piper Sandler 36th Annual Healthcare Conference
PR Newswire
2 months ago
CalciMedica Announces Presentations at Upcoming Medical Meetings
PR Newswire
2 months ago
CalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical & Corporate Updates
PR Newswire
2 months ago
CalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial Officer
Argus Research
3 months ago
Daily – Vickers Top Buyers & Sellers for 11/06/2024
PR Newswire
3 months ago
CalciMedica Announces Pricing of Public Offering of Common Stock
PR Newswire
3 months ago
CalciMedica Announces Proposed Public Offering of Common Stock
Compare CALC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CALC CalciMedica Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.